Nipatra: chewable sildenafil tablet for erectile dysfunction

Amdipharm Mercury has launched a chewable tablet formulation of sildenafil for the treatment of erectile dysfunction.

Chewable sildenafil tablets may be particularly useful for patients with swallowing difficulties.
Chewable sildenafil tablets may be particularly useful for patients with swallowing difficulties.

The mint-flavoured chewable tablet formulation can be prescribed at NHS expense provided the patient meets the criteria set out for erectile dysfunction: it must only be prescribed for men who have:

  • prostate cancer, 
  • kidney failure treated with dialysis or transplantation, 
  • spinal cord injury, 
  • diabetes, 
  • multiple sclerosis, 
  • single gene neurological disease, 
  • spina bifida, 
  • Parkinson's disease, 
  • polio, 
  • severe pelvic injury, or 
  • undergone previous radical pelvic surgery or prostatectomy.

It is also available for men who were already receiving drug treatment for impotence on the NHS on 14 September 1998, and through specialist services for men suffering severe distress because of impotence. 

When prescribed in this way, the prescription must be marked 'SLS'.

View Nipatra drug record

Further information: Amdipharm Mercury

Follow MIMS on Twitter

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases